التفاصيل البيبلوغرافية
| العنوان: |
Utility and diagnostic test properties of pulmonary and cardiovascular point of care ultra-sonography (POCUS) in COVID-19 patients admitted to critical care unit. |
| المؤلفون: |
Kedar Toraskar, Ravindra R. Zore, Gaurav A. Gupta, Bhooshan Gondse, Gurudas Pundpal, Shirishkumar Kadam, Sachin Pawaskar, Maninder Singh Setia |
| المصدر: |
European Journal of Radiology Open, Vol 9, Iss , Pp 100451- (2022) |
| بيانات النشر: |
Elsevier, 2022. |
| سنة النشر: |
2022 |
| المجموعة: |
LCC:Medical physics. Medical radiology. Nuclear medicine |
| مصطلحات موضوعية: |
COVID-19 patient, Point of care ultrasonography, Lung, Cardiovascular system, Diagnostic test properties, mortality, Medical physics. Medical radiology. Nuclear medicine, R895-920 |
| الوصف: |
Background: We conducted this study to assess the diagnostic test properties of point of care ultrasonography (POCUS) of lung and cardiovascular system in prediction of mortality in COVID-19 patients. Methods: This is a cross-sectional study of 178 Covid-19 patients; POCUS was performed within one hour of admission to the ICU. We estimated sensitivity, specificity, positive predictive value, negative predictive value for prediction of mortality. Results: The mean (SD) age of these patients was 57.3 (12.8) years. The findings were on cardiac ultrasonography were: mild pericardial effusion (45%), chamber dilatation (15%), hypokinesia (11%), and low ejection fraction (8%). In our study, 30 patients (17%) had died. A cut-off score of > to 13 (for lung ultrasound score [LUS]) had high sensitivity for mortality (93.3%, 95% CI: 77.9–99.2%). However, low ejection fraction (92.3%, 95% CI: 86,6–96.1%), and thrombosis in either vein (96.5%, 95% CI: 92.0–98.9%) were specific for mortality. A combination of LUS > =13 or low ejection fraction or thrombosis or spontaneous echo contrast (slow flow) improved sensitivity for mortality to 96.7% (95% CI: 82.8–99.9%). The agreement between LUS of > =13 and CT score of moderate/severe was 85.7% (95% CI: 62.8–100%). The interrater agreement between these two parameters was 0.82 (95% CI: 0.68, 0.97). Conclusions: Multi-organ POCUS is effective in diagnosis, prognosis, and management of COVID-19 patients. Rather than just lung ultrasound, clinicians should use multiorgan POCUS for early identification of severe lung involvement and thrombotic changes; it may help reduce mortality in these patients. |
| نوع الوثيقة: |
article |
| وصف الملف: |
electronic resource |
| اللغة: |
English |
| تدمد: |
2352-0477 |
| Relation: |
http://www.sciencedirect.com/science/article/pii/S2352047722000582; https://doaj.org/toc/2352-0477 |
| DOI: |
10.1016/j.ejro.2022.100451 |
| URL الوصول: |
https://doaj.org/article/013be90b85984f4087baa656ad77550e |
| رقم الانضمام: |
edsdoj.013be90b85984f4087baa656ad77550e |
| قاعدة البيانات: |
Directory of Open Access Journals |
Full Text Finder